- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Mukka Proteins Limited has approved its unaudited financial results for the quarter and half-year ended September 30, 2024. Notable figures include a revenue from operations of ₹3,115.60 crore for the half-year, compared to ₹5,905.39 crore for the corresponding period last year. The profit after tax stands at ₹72.98 crore, versus ₹329.81 crore previously. The company has consolidated its increased stake in Ento Proteins Private Limited, now at 74%, effective from September 27, 2024. The meeting reviewed and confirmed these outcomes, which reflect significant operational developments.